Inscripta raises $30 million in capital
BOULDER — Inscripta Inc., a gene-editing technology company, has raised $30 million in capital.
The funding, filed with the U.S. Securities and Exchange Commission in a Form D dated Jan. 17, comes from the company’s existing investors.
In 2018, the Boulder-based company raised $85.5 million, according to a news release. The company raised more than $55 million in February 2018. The funding is an expansion of a Series C round. Investors include Venrock, Foresite, Mérieux Développement, Paladin Capital Group, MLS Capital and NanoDimension.
SPONSORED CONTENT
In September, Inscripta acquired Solana Biosciences.
BOULDER — Inscripta Inc., a gene-editing technology company, has raised $30 million in capital.
The funding, filed with the U.S. Securities and Exchange Commission in a Form D dated Jan. 17, comes from the company’s existing investors.
In 2018, the Boulder-based company raised $85.5 million, according to a news release. The company raised more than $55 million in February 2018. The funding is an expansion of a Series C round. Investors include Venrock, Foresite, Mérieux Développement, Paladin Capital Group, MLS Capital and NanoDimension.
In September, Inscripta acquired Solana Biosciences
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
TiFin Group , a Boulder-based financial technology umbrella company, has offloaded its ownership stake in…
-
Tilt, a human-resources technology platform that helps companies and employees navigate the leave process, has…
-
Broomfield-based Premier Members Credit Union opened a new branch this week at 1425 S. Airport…
-
Ent Credit Union has joined a coalition of credit unions across the country to launch…
